 | • レポートコード：QYR2104Z0408 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、駆虫薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（駆虫薬、抗原虫薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・駆虫薬の市場動向 ・企業の競争状況、市場シェア ・駆虫薬の種類別市場規模（駆虫薬、抗原虫薬、その他） ・駆虫薬の用途別市場規模（病院、クリニック、その他） ・駆虫薬の北米市場規模2016-2027（アメリカ、カナダ） ・駆虫薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・駆虫薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・駆虫薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・駆虫薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ipca Laboratories Ltd、Zydus Cadila、Merck、Pfizer、GlaxoSmithKline Plc.、Cipla Ltd、Ranbaxy Laboratories、Novartis AG、Alvizia Health Care、Bayer AG、Roche Inc、Arbor Pharmaceuticals Inc.、Sanofi、AstraZeneca、Alkem Laboratories Limited） ・結論 |
Market Analysis and Insights: Global Antiparasitic Drugs Market
The global Antiparasitic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antiparasitic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antiparasitic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antiparasitic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antiparasitic Drugs market.
Global Antiparasitic Drugs Scope and Market Size
Antiparasitic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiparasitic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
by Type
Anthelmintics
Antiprotozoals
Others
by Delivery Type
Oral
Injectable
Topical
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Ipca Laboratories Ltd
Zydus Cadila
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Roche Inc
Arbor Pharmaceuticals Inc.
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiparasitic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anthelmintics
1.2.3 Antiprotozoals
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antiparasitic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antiparasitic Drugs Market Perspective (2016-2027)
2.2 Antiparasitic Drugs Growth Trends by Regions
2.2.1 Antiparasitic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antiparasitic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Antiparasitic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Antiparasitic Drugs Industry Dynamic
2.3.1 Antiparasitic Drugs Market Trends
2.3.2 Antiparasitic Drugs Market Drivers
2.3.3 Antiparasitic Drugs Market Challenges
2.3.4 Antiparasitic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiparasitic Drugs Players by Revenue
3.1.1 Global Top Antiparasitic Drugs Players by Revenue (2016-2021)
3.1.2 Global Antiparasitic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antiparasitic Drugs Revenue
3.4 Global Antiparasitic Drugs Market Concentration Ratio
3.4.1 Global Antiparasitic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiparasitic Drugs Revenue in 2020
3.5 Antiparasitic Drugs Key Players Head office and Area Served
3.6 Key Players Antiparasitic Drugs Product Solution and Service
3.7 Date of Enter into Antiparasitic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiparasitic Drugs Breakdown Data by Type
4.1 Global Antiparasitic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Antiparasitic Drugs Forecasted Market Size by Type (2022-2027)
5 Antiparasitic Drugs Breakdown Data by Application
5.1 Global Antiparasitic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Antiparasitic Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Antiparasitic Drugs Market Size (2016-2027)
6.2 North America Antiparasitic Drugs Market Size by Type
6.2.1 North America Antiparasitic Drugs Market Size by Type (2016-2021)
6.2.2 North America Antiparasitic Drugs Market Size by Type (2022-2027)
6.2.3 North America Antiparasitic Drugs Market Size by Type (2016-2027)
6.3 North America Antiparasitic Drugs Market Size by Application
6.3.1 North America Antiparasitic Drugs Market Size by Application (2016-2021)
6.3.2 North America Antiparasitic Drugs Market Size by Application (2022-2027)
6.3.3 North America Antiparasitic Drugs Market Size by Application (2016-2027)
6.4 North America Antiparasitic Drugs Market Size by Country
6.4.1 North America Antiparasitic Drugs Market Size by Country (2016-2021)
6.4.2 North America Antiparasitic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Antiparasitic Drugs Market Size (2016-2027)
7.2 Europe Antiparasitic Drugs Market Size by Type
7.2.1 Europe Antiparasitic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Antiparasitic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Antiparasitic Drugs Market Size by Type (2016-2027)
7.3 Europe Antiparasitic Drugs Market Size by Application
7.3.1 Europe Antiparasitic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Antiparasitic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Antiparasitic Drugs Market Size by Application (2016-2027)
7.4 Europe Antiparasitic Drugs Market Size by Country
7.4.1 Europe Antiparasitic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Antiparasitic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Antiparasitic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Antiparasitic Drugs Market Size by Type
8.2.1 Asia-Pacific Antiparasitic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antiparasitic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antiparasitic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Antiparasitic Drugs Market Size by Application
8.3.1 Asia-Pacific Antiparasitic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antiparasitic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antiparasitic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Antiparasitic Drugs Market Size by Region
8.4.1 Asia-Pacific Antiparasitic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antiparasitic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antiparasitic Drugs Market Size (2016-2027)
9.2 Latin America Antiparasitic Drugs Market Size by Type
9.2.1 Latin America Antiparasitic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Antiparasitic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Antiparasitic Drugs Market Size by Type (2016-2027)
9.3 Latin America Antiparasitic Drugs Market Size by Application
9.3.1 Latin America Antiparasitic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Antiparasitic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Antiparasitic Drugs Market Size by Application (2016-2027)
9.4 Latin America Antiparasitic Drugs Market Size by Country
9.4.1 Latin America Antiparasitic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Antiparasitic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiparasitic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Antiparasitic Drugs Market Size by Type
10.2.1 Middle East & Africa Antiparasitic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antiparasitic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antiparasitic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Antiparasitic Drugs Market Size by Application
10.3.1 Middle East & Africa Antiparasitic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antiparasitic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antiparasitic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Antiparasitic Drugs Market Size by Country
10.4.1 Middle East & Africa Antiparasitic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antiparasitic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ipca Laboratories Ltd
11.1.1 Ipca Laboratories Ltd Company Details
11.1.2 Ipca Laboratories Ltd Business Overview
11.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Introduction
11.1.4 Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2016-2021)
11.1.5 Ipca Laboratories Ltd Recent Development
11.2 Zydus Cadila
11.2.1 Zydus Cadila Company Details
11.2.2 Zydus Cadila Business Overview
11.2.3 Zydus Cadila Antiparasitic Drugs Introduction
11.2.4 Zydus Cadila Revenue in Antiparasitic Drugs Business (2016-2021)
11.2.5 Zydus Cadila Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Antiparasitic Drugs Introduction
11.3.4 Merck Revenue in Antiparasitic Drugs Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Antiparasitic Drugs Introduction
11.4.4 Pfizer Revenue in Antiparasitic Drugs Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline Plc.
11.5.1 GlaxoSmithKline Plc. Company Details
11.5.2 GlaxoSmithKline Plc. Business Overview
11.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Introduction
11.5.4 GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Plc. Recent Development
11.6 Cipla Ltd
11.6.1 Cipla Ltd Company Details
11.6.2 Cipla Ltd Business Overview
11.6.3 Cipla Ltd Antiparasitic Drugs Introduction
11.6.4 Cipla Ltd Revenue in Antiparasitic Drugs Business (2016-2021)
11.6.5 Cipla Ltd Recent Development
11.7 Ranbaxy Laboratories
11.7.1 Ranbaxy Laboratories Company Details
11.7.2 Ranbaxy Laboratories Business Overview
11.7.3 Ranbaxy Laboratories Antiparasitic Drugs Introduction
11.7.4 Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2016-2021)
11.7.5 Ranbaxy Laboratories Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Antiparasitic Drugs Introduction
11.8.4 Novartis AG Revenue in Antiparasitic Drugs Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 Alvizia Health Care
11.9.1 Alvizia Health Care Company Details
11.9.2 Alvizia Health Care Business Overview
11.9.3 Alvizia Health Care Antiparasitic Drugs Introduction
11.9.4 Alvizia Health Care Revenue in Antiparasitic Drugs Business (2016-2021)
11.9.5 Alvizia Health Care Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Antiparasitic Drugs Introduction
11.10.4 Bayer AG Revenue in Antiparasitic Drugs Business (2016-2021)
11.10.5 Bayer AG Recent Development
11.11 Roche Inc
11.11.1 Roche Inc Company Details
11.11.2 Roche Inc Business Overview
11.11.3 Roche Inc Antiparasitic Drugs Introduction
11.11.4 Roche Inc Revenue in Antiparasitic Drugs Business (2016-2021)
11.11.5 Roche Inc Recent Development
11.12 Arbor Pharmaceuticals Inc.
11.12.1 Arbor Pharmaceuticals Inc. Company Details
11.12.2 Arbor Pharmaceuticals Inc. Business Overview
11.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Introduction
11.12.4 Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2016-2021)
11.12.5 Arbor Pharmaceuticals Inc. Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Antiparasitic Drugs Introduction
11.13.4 Sanofi Revenue in Antiparasitic Drugs Business (2016-2021)
11.13.5 Sanofi Recent Development
11.14 AstraZeneca
11.14.1 AstraZeneca Company Details
11.14.2 AstraZeneca Business Overview
11.14.3 AstraZeneca Antiparasitic Drugs Introduction
11.14.4 AstraZeneca Revenue in Antiparasitic Drugs Business (2016-2021)
11.14.5 AstraZeneca Recent Development
11.15 Alkem Laboratories Limited
11.15.1 Alkem Laboratories Limited Company Details
11.15.2 Alkem Laboratories Limited Business Overview
11.15.3 Alkem Laboratories Limited Antiparasitic Drugs Introduction
11.15.4 Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2016-2021)
11.15.5 Alkem Laboratories Limited Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Antiparasitic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anthelmintics
Table 3. Key Players of Antiprotozoals
Table 4. Key Players of Others
Table 5. Global Antiparasitic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Antiparasitic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antiparasitic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Antiparasitic Drugs Market Share by Regions (2016-2021)
Table 9. Global Antiparasitic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Antiparasitic Drugs Market Share by Regions (2022-2027)
Table 11. Antiparasitic Drugs Market Trends
Table 12. Antiparasitic Drugs Market Drivers
Table 13. Antiparasitic Drugs Market Challenges
Table 14. Antiparasitic Drugs Market Restraints
Table 15. Global Antiparasitic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Antiparasitic Drugs Market Share by Players (2016-2021)
Table 17. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiparasitic Drugs as of 2020)
Table 18. Ranking of Global Top Antiparasitic Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Antiparasitic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antiparasitic Drugs Product Solution and Service
Table 22. Date of Enter into Antiparasitic Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Antiparasitic Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Antiparasitic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Antiparasitic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Antiparasitic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Antiparasitic Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Antiparasitic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Antiparasitic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Antiparasitic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Antiparasitic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Antiparasitic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Antiparasitic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antiparasitic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Antiparasitic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Antiparasitic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Antiparasitic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antiparasitic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Antiparasitic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Ipca Laboratories Ltd Company Details
Table 63. Ipca Laboratories Ltd Business Overview
Table 64. Ipca Laboratories Ltd Antiparasitic Drugs Product
Table 65. Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 66. Ipca Laboratories Ltd Recent Development
Table 67. Zydus Cadila Company Details
Table 68. Zydus Cadila Business Overview
Table 69. Zydus Cadila Antiparasitic Drugs Product
Table 70. Zydus Cadila Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 71. Zydus Cadila Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Antiparasitic Drugs Product
Table 75. Merck Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Antiparasitic Drugs Product
Table 80. Pfizer Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. GlaxoSmithKline Plc. Company Details
Table 83. GlaxoSmithKline Plc. Business Overview
Table 84. GlaxoSmithKline Plc. Antiparasitic Drugs Product
Table 85. GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 86. GlaxoSmithKline Plc. Recent Development
Table 87. Cipla Ltd Company Details
Table 88. Cipla Ltd Business Overview
Table 89. Cipla Ltd Antiparasitic Drugs Product
Table 90. Cipla Ltd Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 91. Cipla Ltd Recent Development
Table 92. Ranbaxy Laboratories Company Details
Table 93. Ranbaxy Laboratories Business Overview
Table 94. Ranbaxy Laboratories Antiparasitic Drugs Product
Table 95. Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 96. Ranbaxy Laboratories Recent Development
Table 97. Novartis AG Company Details
Table 98. Novartis AG Business Overview
Table 99. Novartis AG Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 100. Novartis AG Recent Development
Table 101. Alvizia Health Care Company Details
Table 102. Alvizia Health Care Business Overview
Table 103. Alvizia Health Care Antiparasitic Drugs Product
Table 104. Alvizia Health Care Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 105. Alvizia Health Care Recent Development
Table 106. Bayer AG Company Details
Table 107. Bayer AG Business Overview
Table 108. Bayer AG Antiparasitic Drugs Product
Table 109. Bayer AG Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 110. Bayer AG Recent Development
Table 111. Roche Inc Company Details
Table 112. Roche Inc Business Overview
Table 113. Roche Inc Antiparasitic Drugs Product
Table 114. Roche Inc Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 115. Roche Inc Recent Development
Table 116. Arbor Pharmaceuticals Inc. Company Details
Table 117. Arbor Pharmaceuticals Inc. Business Overview
Table 118. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product
Table 119. Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 120. Arbor Pharmaceuticals Inc. Recent Development
Table 121. Sanofi Company Details
Table 122. Sanofi Business Overview
Table 123. Sanofi Antiparasitic Drugs Product
Table 124. Sanofi Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 125. Sanofi Recent Development
Table 126. AstraZeneca Company Details
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Antiparasitic Drugs Product
Table 129. AstraZeneca Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 130. AstraZeneca Recent Development
Table 131. Alkem Laboratories Limited Company Details
Table 132. Alkem Laboratories Limited Business Overview
Table 133. Alkem Laboratories Limited Antiparasitic Drugs Product
Table 134. Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million)
Table 135. Alkem Laboratories Limited Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiparasitic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Anthelmintics Features
Figure 3. Antiprotozoals Features
Figure 4. Others Features
Figure 5. Global Antiparasitic Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Antiparasitic Drugs Report Years Considered
Figure 10. Global Antiparasitic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Antiparasitic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Antiparasitic Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Antiparasitic Drugs Market Share by Regions (2022-2027)
Figure 14. Global Antiparasitic Drugs Market Share by Players in 2020
Figure 15. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiparasitic Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Antiparasitic Drugs Revenue in 2020
Figure 17. Global Antiparasitic Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Antiparasitic Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Antiparasitic Drugs Market Share by Type (2016-2027)
Figure 21. North America Antiparasitic Drugs Market Share by Application (2016-2027)
Figure 22. North America Antiparasitic Drugs Market Share by Country (2016-2027)
Figure 23. United States Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Antiparasitic Drugs Market Share by Type (2016-2027)
Figure 27. Europe Antiparasitic Drugs Market Share by Application (2016-2027)
Figure 28. Europe Antiparasitic Drugs Market Share by Country (2016-2027)
Figure 29. Germany Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Antiparasitic Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Antiparasitic Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Antiparasitic Drugs Market Share by Region (2016-2027)
Figure 39. China Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Antiparasitic Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Antiparasitic Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Antiparasitic Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Antiparasitic Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Antiparasitic Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Antiparasitic Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Ipca Laboratories Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 59. Zydus Cadila Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 62. GlaxoSmithKline Plc. Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 63. Cipla Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 64. Ranbaxy Laboratories Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 65. Novartis AG Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 66. Alvizia Health Care Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 67. Bayer AG Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 68. Roche Inc Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 69. Arbor Pharmaceuticals Inc. Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 71. AstraZeneca Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 72. Alkem Laboratories Limited Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed